Detalles de la búsqueda
1.
Impact of elranatamab on quality of life: Patient-reported outcomes from MagnetisMM-3.
Br J Haematol
; 204(5): 1801-1810, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38420657
2.
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
N Engl J Med
; 384(12): 1101-1112, 2021 03 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33761207
3.
Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma.
Future Oncol
; 2024 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38415370
4.
Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial.
Lancet
; 400(10348): 273-282, 2022 07 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35871814
5.
Comparing g-computation, propensity score-based weighting, and targeted maximum likelihood estimation for analyzing externally controlled trials with both measured and unmeasured confounders: a simulation study.
BMC Med Res Methodol
; 23(1): 18, 2023 01 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36647031
6.
Improvements in Disease Activity Partially Mediate the Effect of Tofacitinib Treatment on Generic and Disease-Specific Health-Related Quality of Life in Patients with Ulcerative Colitis: Data from the OCTAVE Program.
Dig Dis
; 41(4): 604-614, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36603566
7.
Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study.
J Eur Acad Dermatol Venereol
; 37(10): 2056-2066, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37335885
8.
Predictors of nonresponse to dupilumab in patients with atopic dermatitis: A machine learning analysis.
Ann Allergy Asthma Immunol
; 129(3): 354-359.e5, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35640774
9.
Retrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative Colitis.
Dig Dis
; 40(5): 553-564, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34879378
10.
Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial.
J Am Acad Dermatol
; 86(1): 104-112, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34416294
11.
The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and Europe.
BMC Gastroenterol
; 20(1): 18, 2020 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31964359
12.
Use of the SF-36v2 Health Survey as a Screen for Risk of Major Depressive Disorder in a US Population-based Sample and Subgroup With Chronic Pain.
Med Care
; 55(2): 111-116, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27517330
13.
A cross-sectional assessment of the prevalence and burden of mild asthma in urban China using the 2010, 2012, and 2013 China National Health and Wellness Surveys.
J Asthma
; 54(6): 632-643, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28001469
14.
Patient preferences for treatment of castration-resistant prostate cancer in Japan: a discrete-choice experiment.
BMC Urol
; 16(1): 63, 2016 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27814714
15.
Predictors of self-reported benign prostatic hyperplasia in European men: analysis of the European National Health and Wellness Survey.
World J Urol
; 33(5): 639-47, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25100623
16.
The societal burden of chronic pain in Japan: an internet survey.
J Orthop Sci
; 20(4): 750-60, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25963609
17.
Quantifying the burden of informal caregiving for patients with cancer in Europe.
Support Care Cancer
; 22(6): 1637-46, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24496758
18.
Prevalence of pain reporting and associated health outcomes across emerging markets and developed countries.
Pain Med
; 15(11): 1880-91, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25220263
19.
Assessment of algorithms for identifying patients with triple-class refractory multiple myeloma using real-world data.
Curr Med Res Opin
; 40(5): 789-801, 2024 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38523576
20.
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2.
Am J Clin Dermatol
; 25(1): 127-138, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37624488